ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $12,000 | -52.0% | 11,374 | -17.6% | 0.00% | – |
| Q3 2021 | $25,000 | -68.8% | 13,796 | -54.7% | 0.00% | – |
| Q2 2021 | $80,000 | -31.6% | 30,451 | -6.4% | 0.00% | – |
| Q1 2021 | $117,000 | +37.6% | 32,526 | -3.3% | 0.00% | – |
| Q4 2020 | $85,000 | -22.7% | 33,651 | -23.1% | 0.00% | – |
| Q3 2020 | $110,000 | -20.9% | 43,776 | +3.2% | 0.00% | – |
| Q2 2020 | $139,000 | +44.8% | 42,436 | +8.6% | 0.00% | – |
| Q1 2020 | $96,000 | -49.2% | 39,076 | -2.3% | 0.00% | – |
| Q4 2019 | $189,000 | +8.6% | 39,988 | -1.4% | 0.00% | – |
| Q3 2019 | $174,000 | -32.0% | 40,565 | -7.6% | 0.00% | -100.0% |
| Q2 2019 | $256,000 | +55.2% | 43,921 | +2.3% | 0.00% | – |
| Q1 2019 | $165,000 | +108.9% | 42,921 | +1.7% | 0.00% | – |
| Q4 2018 | $79,000 | -45.9% | 42,196 | -7.4% | 0.00% | – |
| Q3 2018 | $146,000 | +2.8% | 45,571 | -3.4% | 0.00% | – |
| Q2 2018 | $142,000 | -22.4% | 47,175 | +0.9% | 0.00% | -100.0% |
| Q1 2018 | $183,000 | -4.7% | 46,775 | +0.9% | 0.00% | 0.0% |
| Q4 2017 | $192,000 | +140.0% | 46,343 | +257.1% | 0.00% | – |
| Q3 2017 | $80,000 | -1.2% | 12,977 | -0.7% | 0.00% | – |
| Q2 2017 | $81,000 | -2.4% | 13,073 | -0.5% | 0.00% | -100.0% |
| Q1 2017 | $83,000 | +20.3% | 13,143 | +7.6% | 0.00% | 0.0% |
| Q3 2016 | $69,000 | -4.2% | 12,220 | +1.5% | 0.00% | 0.0% |
| Q2 2016 | $72,000 | -76.8% | 12,039 | -70.1% | 0.00% | 0.0% |
| Q1 2016 | $311,000 | +55.5% | 40,210 | +60.3% | 0.00% | 0.0% |
| Q4 2015 | $200,000 | +669.2% | 25,078 | +145.9% | 0.00% | – |
| Q3 2014 | $26,000 | -56.7% | 10,200 | -22.7% | 0.00% | – |
| Q1 2014 | $60,000 | -9.1% | 13,200 | -13.2% | 0.00% | – |
| Q4 2013 | $66,000 | -4.3% | 15,200 | -4.4% | 0.00% | – |
| Q3 2013 | $69,000 | +102.9% | 15,900 | 0.0% | 0.00% | – |
| Q2 2013 | $34,000 | – | 15,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |